Jim Cramer on Vertex Pharmaceuticals: “I Wish I Had Bought It for the Charitable Trust a Long Time Ago” [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
I think Vertex is very strong. I wish I had bought it for the Charitable Trust a long time ago, when we had the CEO on. It was an excellent call, and then I got cold feet. That was a mistake. It's a good buy. Stock market data. Photo by Burak The Weekender on Pexels Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) develops and commercializes transformative medicines for serious conditions, including cystic fibrosis, sickle cell disease, and acute pain. Hardman Johnston Global Equity Strategy stated the following regarding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) in its fourth quarter 2025 investor letter During the quarter we liquidated Corteva Inc., T-Mobile US, Inc. and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). After meetings with FDA, Vertex Pharmaceuticals Inc. does not see a path forward for a broad neuropathic chronic pain label for Journavx. This lowered potential TAM of Journavx in chronic pain. VX-993 (next generation NaV 1.8) phase II data failed to
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Is Halozyme Therapeutics (HALO) One of the Most Undervalued Biotech Stocks to Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- 2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- 2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Yahoo! Finance]Yahoo! Finance
- How an unsolved medical mystery became a life-saving breakthrough [USA TODAY]USA TODAY
- Is Vertex Pharmaceuticals' Empire in Trouble? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- VRTX's page on the SEC website